SCHEMBL4929175

SCHEMBL4929175

CCN(CC)c1ccc2c(C)c(-c3ccc4c(ccn4C(=O)OC(C)(C)C)c3)c(=O)oc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EP300 Q09472 1/20 0.56
▸ ALDH1A1 P00352 11/20 0.56
▸ KDM4E B2RXH2 8/20 0.56
▸ MAPT P10636 6/20 0.56
▸ HPGD P15428 5/20 0.56
▸ L3MBTL1 Q9Y468 4/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ HIF1A Q16665 2/20 0.56
▸ ATM Q13315 7/20 0.47
▸ HTT P42858 6/20 0.47
▸ HSD17B10 Q99714 6/20 0.47
▸ GLA P06280 5/20 0.47
▸ CASP1 P29466 5/20 0.47
▸ CASP7 P55210 5/20 0.47
▸ LMNA P02545 3/20 0.47
▸ THRB P10828 1/20 0.47
▸ GAA P10253 2/20 0.47
▸ KLK7 P49862 1/20 0.47
▸ TDP1 Q9NUW8 3/20 0.46
▸ MEN1 O00255 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4927809 0.94 ALDH1A1 (0.55) EP300ALDH1A1KDM4EMAPTHPGD
SCHEMBL3835028 0.81 MAPT (0.43) ALDH1A1KDM4EMAPTHPGDL3MBTL1
SCHEMBL13869309 0.76 ALDH1A1 (0.86) EP300ALDH1A1KDM4EMAPTHPGD
SCHEMBL13869681 0.76 ALDH1A1 (0.70) EP300ALDH1A1KDM4EMAPTHPGD
SCHEMBL4919783 0.75 CA12 (0.50) ALDH1A1KDM4EMAPTHPGDL3MBTL1
SCHEMBL808511 0.74 ALDH1A1 (0.73) EP300ALDH1A1KDM4EMAPTHPGD
SCHEMBL4922302 0.73 ALDH1A1 (0.51) EP300ALDH1A1KDM4EMAPTHPGD
SCHEMBL30914647 0.73 ALDH1A1 (0.69) EP300ALDH1A1KDM4EMAPTHPGD
SCHEMBL29249873 0.73 ALDH1A1 (0.69) EP300ALDH1A1KDM4EMAPTHPGD
SCHEMBL13869289 0.73 ALDH1A1 (0.72) EP300ALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT EP300 2515/4885ALDH1A1 181/4885KDM4E 1183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback